Clinical Applications of Microalbuminuria

Jayamathi Govindaraj, K. Govindaraj, S.Bhuminathan, K. Padmavathy
{"title":"Clinical Applications of Microalbuminuria","authors":"Jayamathi Govindaraj, K. Govindaraj, S.Bhuminathan, K. Padmavathy","doi":"10.25163/angiotherapy.52221492618181221","DOIUrl":null,"url":null,"abstract":"Microalbuminuria is a marker for generalized vascular dysfunction. Persistent microalbuminuria indicates a high probability of damage to the glomerular filtration capacity of the kidney and is of great diagnostic relevance. Albuminuria has also been shown more recently to be a predictor of cardiovascular outcomes. Emerging data that reduces albuminuria leads to reduced risk of adverse renal and cardiovascular events, and steps should be taken to suppress albuminuria to prevent future renal and cardiovascular adverse events. This review discusses the measurement of albuminuria and summarizes the current literature on the association between albuminuria and adverse cardiovascular and renal outcomes in type 2 diabetes and hypertension.","PeriodicalId":154960,"journal":{"name":"Journal of Angiotherapy","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Angiotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25163/angiotherapy.52221492618181221","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Microalbuminuria is a marker for generalized vascular dysfunction. Persistent microalbuminuria indicates a high probability of damage to the glomerular filtration capacity of the kidney and is of great diagnostic relevance. Albuminuria has also been shown more recently to be a predictor of cardiovascular outcomes. Emerging data that reduces albuminuria leads to reduced risk of adverse renal and cardiovascular events, and steps should be taken to suppress albuminuria to prevent future renal and cardiovascular adverse events. This review discusses the measurement of albuminuria and summarizes the current literature on the association between albuminuria and adverse cardiovascular and renal outcomes in type 2 diabetes and hypertension.
微量白蛋白尿的临床应用
微量白蛋白尿是全身性血管功能障碍的标志。持续性微量白蛋白尿表明肾小球滤过能力受损的可能性很高,具有重要的诊断意义。蛋白尿最近也被证明是心血管疾病的预测指标。新出现的数据表明,减少蛋白尿可降低肾脏和心血管不良事件的风险,应采取措施抑制蛋白尿以预防未来的肾脏和心血管不良事件。本文讨论了蛋白尿的测量,并总结了目前关于蛋白尿与2型糖尿病和高血压患者心血管和肾脏不良结局之间关系的文献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信